4-Hydroxyphenylpyruvate dioxygenase (4-HPPD), one of the target enzymes for bleaching herbicides, was known to be deactivated by making a Fe 2ϩ -chelate combination with inhibitors at its active site. Complexation abilities of 1-phenylbutane-1,3-dione derivative, 2-cyano-4-phenylbutane-1,3-dione derivative, benzoylcyclohexane-1,3-diones and benzoylpyrazole derivatives with Fe 2ϩ was demonstrated by spectrophotometric analysis under different concentrations of iron (II) sulfate aqueous solution. The active forms of pyrazolate in the presence of Fe 2ϩ showed large changes in UV absorbance, whereas no apparent changes were observed with non 4-HPPD inhibiting compounds. UV analysis using iron (II) sulfate aqueous solution was a convenient method before 4-HPPD-inhibiting assay and pot test with intact plants in the screening of novel candidates for 4-HPPD inhibitors.
Introduction
A plant enzyme, 4-hydroxyphenylpyruvate dioxygenase (4-HPPD, EC 1.13.11.27), which catalyzes the oxygenation of 4-hydroxyphenylpyruvate (4-HPPA) to form homogentisate (HGA), plays an important role in plastoquinone biosynthesis. [1] [2] [3] [4] The enzyme is the molecular target site for one of the bleaching herbicides having a 1,3-diketone moiety for herbicidal activity, for example, pyrazolate (4-(2,4-dichlorobenzoyl)-1,3-dimethylpyrazol-5-yl p-toluenesulfonate), benzobicyclone (3-[2-chloro-4-(methylsulfonyl)benzoyl]-4-(phenylthio)bicyclo[3.2.1]oct-3-en-2-one) and isoxaflutole (5-cyclopropyl-4-(2-methylsulfonyl-4-trifluoromethylbenzoyl)isoxazole). [5] [6] [7] These inhibitors caused a reduction in the plastoquinone level in plants as its main herbicidal effect. Plastoquinone is the redox cofactor for accepting hydrogen from enzymatic desaturation caused by phytoene desaturase in carotenoid biosynthesis. A reduction of the plastoquinone level prevents the production of precursors of carotenogenesis, interfering with the biosynthesis of carotenoids, and the bleaching phenomenon was observed in the plants. 8, 9) 4-HPPD inhibitors block the enzyme by chelation with Fe 2ϩ at the active site by a 1,3-dicarbonyl moiety, in a manner similar to 4-HPPA.
10) The crystal structures of the 4-HPPD from Arabidopsis thaliana with and without herbicidal inhibitors were determined by Yang et al. and it was reported that the 1,3-diketone moiety of DAS869 (1-tert-butyl-5-hydroxy-4-[3-(4-methoxyphenyl)-2-methyl-4-methylsulfonylbenzoyl]pyrazole), a potent 4-HPPD inhibitor, coordinated to Fe 2ϩ at the active site of 4-HPPD. 11) It is known that a change in the UV spectrum is observed after the formation of a chelate combination between the compounds and metal ions. 12) In this paper, UV spectra using one diketone analog, one diketonitrile analog, two benzoylcyclohexane-1,3-diones, including sulcotrione, and nine kinds of benzoylpyrazole derivatives, were measured in the presence of Fe , and the 4-HPPD inhibitory activities of these compounds were evaluated. In addition, the correlations between the changes in their UV absorbance and 4-HPPD inhibitory activities were discussed.
Materials and Methods

Synthesis
4-(2-Chlorobenzoyl)-5-hydroxy-1,3-dimethylpyrazole
(4) 5-Hydroxy-1,3-dimethylpyrazole (1.45 g, 12.9 mmol) was added to a dichloromethane solution (15 ml) of 2-chlorobenzoyl chloride (1.5 g, 8.57 mmol) and triethylamine (1.79 ml, 12.9 mmol) with cooling in an ice-cold water bath, and the mixture was stirred at room temperature for 8 hr. Triethylamine (1.79 ml, 12.9 mmol) and acetonecyanohydrine (0.09 ml, 0.89 mmol) were added to the mixture and stirred at room temperature overnight. The resulting mixture was quenched with 1 M-hydrochloric acid solution (30 ml) and extracted twice with ethyl acetate (30 mlϫ2). The combined organic layers were washed with water twice (30 mlϫ2), dried over anhydrous magnesium sulfate and evaporated in vacuo. Other 4-(substituted benzoyl)pyrazoles (1, 3 and 5-8) were synthesized similarly to the above method.
4-(2,4-Dichlrorobenzoyl)-5-methoxy-1,3-dimethylpyrazole (2)
Methyl iodide (248 mg, 1.75 mmol) and potassium carbonate (363 mg, 2.63 mmol) were added to a 4-(2,4-dichlrorobenzoyl)-5-hydroxy-1,3-dimethylpyrazole (500 mg, 1.75 mmol) in DMF (10 ml) at room temperature, and the mixture was stirred at room temperature for 12 hr. The resulting mixture was quenched with 1 M-hydrochloric acid solution (30 ml) and extracted twice with ethyl acetate (30 mlϫ2). The combined organic layers were washed with water, dried over anhydrous magnesium sulfate and evaporated in vacuo. The solid obtained was washed with n-hexane and well dried to give 4-(2,4-dichlrorobenzoyl)-5-methoxy-1,3-dimethylpyrazole (176 mg, 0.59 mmol) in 34% yield as a colorless solid. mp: 88-91°C; 1 
4-(2-Aminobenzoyl)-5-hydroxy-1,3-dimethylpyrazole (9)
4-(2-Nitrobenzoyl)-5-hydroxy-1,3-dimethylpyrazole (300 mg, 1.15 mmol), toluene (10 ml) and 10% palladium on charcoal (100 mg) were placed in a stainless steel autoclave, and mixture was stirred under 4 atmospheric pressure of hydrogen gas at 100°C until the gas was no longer absorbed. After the reaction, the catalyst was filtered off and the filtrate was evaporated in vacuo. The obtained residue was well dried to give 4-(2-aminobenzoyl)-5-hydroxy-1,3-dimethylpyrazole (195 mg, 0.84 mmol) in 73% yield as brown oil. 
Preparation of the recombinant 4-HPPD
The recombinant 4-HPPD from Arabidopsis thaliana was prepared based on the method of Lederer et al. 13 ) Recombinant 4-HPPD was overexpressed in E. coli JM109 with 4-HPPDpQE31 plasmid. The cells were grown at 37°C for 8 hr LB medium. Expression of the vector was induced by IPTG (1 mM) when bacterial growth was equivalent to an O.D. 600 of 0.6. The cells were grown for another 17 hr at 22°C and harvested by centrifugation (6,000ϫg). The pellet was resuspended in Tris-HCl buffer (50 mM; pH 7.5) containing 1 mM dithiothreitol, 1 mg/ml lysozyme, and 50 mg/ml DNase. The cells were lysed with a French press at 60 MPa. A crude enzyme preparation was obtained by centrifugation at 13,000ϫg for 15 min at 4°C.
Assay of 4-HPPD inhibitory activity
The 4-HPPD inhibitory activity was evaluated according to Garcia et al. with some modification. 14) One microliter of a methanolic stock solution of a tested compound was added to a mixture of crude enzyme preparation (20 ml) and assay buffer containing 50 mM sodium ascorbate and 10 mM 4-HPPA in 100 mM Tris-HCl, pH 7.5 (175 ml). The assay mixture was incubated for 15 min on ice, and another 15 min at 30°C. The reaction was stopped by the addition of perchloric acid (70 ml, 20% (v/v)). The precipitated protein was removed by centrifugation at 13,000ϫg for 5 min. The supernatant was subjected to HPLC analysis for the determination of HGA production according to Viviani et al. with some modifications. 6 ) Evaluation of 4-HPPD inhibition is presented as pI 50 values, the negative logarithms of the molar concentration at which the compounds produced a 50% inhibition of HGA.
Measurement of UV spectra
UV spectra were measured with a scanning UV-visible spectrophotometer. Compound chelating with Fe 2ϩ was performed in 1.5 ml reaction tubes. A 1 ml final volume of the reaction mixture contained 100 mM of sodium acetate buffer (pH 4.8), 1 mM hydroxylammonium chloride and 2ϫ10 Ϫ5 M of a tested compound. A ferrous sulfate aqueous solution was added to the mixture at a final concentration of 1.2ϫ10 Ϫ5 to 2ϫ10 Ϫ5 M. The resulting solution was stirred for 15 s with a vortex mixer and allowed to stand for 15 min at room temperature to ensure the chelating reaction before the spectra were recorded. The UV spectra were measured in the range of 190 nm to 400 nm to determine the characteristic absorbance at around 260 nm.
Results and Discussion
4-HPPD inhibition
Inhibitory activities (pI 50 values) evaluated using recombinant 4-HPPD from A. thaliana are shown in Table 1 . 2,4-Dichlorobenzoyl analog (1, DTP) was the most potent 4-HPPD inhibitor among the benzoylpyrazoles tested, exhibiting a pI 50 value of 6.60. Non-substituted benzoylpyrazole derivative (3) had no 4-HPPD inhibitory activity. Although no obvious inhibition was observed in the testing of both 4-chlorobenzoyl analog (6) and 3-chlorobenzoyl analog (5), 2-chlorobenzoyl analog (4) exhibited moderate inhibitory activity (pI 50 5.33). This may suggest that introduction of a chlorine atom at ortho-position on the benzoyl group plays an important role in inducing 4-HPPD inhibition, giving an impetus to investigate the effect of other substituents on the benzoyl moiety.
In the trial, 2-methylbenzoyl analog (7) and the 2-nitrobenzoyl analog (8) showed a moderate level of 4-HPPD inhibitory activity, exhibiting pI 50 values 5.64 and 5.30, respectively. On the other hand, 2-aminobenzoyl analog (9) had no 4-HPPD inhibitory activity. These results may suggested that the difference in substituents on the benezene ring induced changes in the preferable chelating distance, which it is important to chelate with Fe 2ϩ at the active site of 4-HPPD, between the carbonyl group and the hydroxy group. In addition to the effect of the substituents on the ortho-position of the benzoyl moiety, methoxypyrazole (2), having no free hydroxy group at 5 position on the pyrazole ring, showed no 4-HPPD inhibitory activity.
In order to discuss the relationship between 4-HPPD inhibition and the change of UV absorbance, a diketone analog (10), a diketonitrile analog (11) and benzoylcyclohexane-1,3-diones (12, 13), including sulcotrione, were also subjected to a 4-HPPD-inhibiting assay. The diketonitrile analog (11) and benzoylcyclohexane-1,3-diones (12, 13) exhibited potent 4-HPPD inhibitory activity, with pI 50 values of 7.09, 7.06 and 6.64, respectively. The diketone analog (10) showed moderate 4-HPPD inhibition (pI 50 5.59) because of the lack of a electron-withdrawing group, such as a cyano or carbonyl group.
Changes of UV absorbance
First, the UV spectrum of 2,4-dichlorobenzoyl analog (1, DTP), which was the most potent 4-HPPD inhibitor in our evaluation of the benzoylpyrazole series, was measured in the presence of Fe 2ϩ at various concentrations. The absorbance of DTP at 261 nm increased markedly depending upon the Fe 2ϩ concentration ( Fig. 1(A) ). Namely, as the Fe 2ϩ concentration increased, the change in UV absorbance became larger. 5-Methoxy analog (2) , showing no 4-HPPD inhibition, did not cause a change in UV absorbance even at higher concentrations of Fe 2ϩ ( Fig. 1(B) ). These results suggested that the detection of chelate formation by UV analysis may be useful to survey 4-HPPD inhibitory activity at the first screening. The effect of substituents of benzoylpyrazole series on chelate formation with Fe 2ϩ was examined. All analogs with no 4-HPPD inhibitory activity (3, 5, 6) did not cause any changes (data not shown). On the other hand, 2-chlorobenzoylpyrazole analog (4), 2-methylbenzoylpyrazole analog (7) and 2-nitrobenzoylpyrazole analog (8) , showing moderate inhibiting activity on 4-HPPD enzyme, showed some changes in UV absorbance in the presence of Fe 2ϩ ( Fig. 1(C) , (D) and (E)). Finally, the UV absorbance of a diketone analog (10), a diketonitrile analog (11) and benzoylcyclohexane-1,3-diones (12, 13) in the presence of various concentration of Fe 2ϩ was determined. Benzoylcyclohexane-1,3-diones (12, 13) showed marked changes in UV absorbance at 261 nm depending on the Fe 2ϩ concentration ( Fig. 1(H) and (I) ). A diketone analog (10) and a diketonitrile analog (11) induced some changes in UV absorbance around 260 nm in the presence of Fe 2ϩ ( Fig. 1(F)  and (G) ). It became clear that there was a correlation between 4-HPPD inhibitory activity and the change in UV absorbance in the presence of Fe 2ϩ . Pallett described that 4-HPPD inhibitors mimic chelation with the substrate 4-HPPA to an enzyme-bound Fe 2ϩ at the active site.
1) It was here clarified that 4-HPPD inhibitors showed marked changes in UV absorbance in the presence of Fe 2ϩ caused by chelate formation. Since chelate formation between Fe 2ϩ and the inhibitor is essential for exhibiting 4-HPPD inhibition, spectrophotometric analysis of iron (II) sulfate aqueous solution may provide an effective and convenient direct method before the enzyme assay and with intact plants for screening novel 4-HPPD inhibitors.
